News

Eledon Pharmaceuticals is poised to revolutionize kidney transplant care with tegoprubart, targeting a $6B market. Read why ...
Obesity is in the news because of a new weight-loss drug in the form of a pill that can be taken any time of day, with or ...
Do you know which goods you should always buy generic instead of opting for the name brands? You might be surprised by some ...
Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.
How can policy makers and health care leaders ensure affordable, equitable access to GLP-1 medications while managing their ...
DHE is a migraine-specific acute medication first approved in 1946. The FDA's approval of the nasal powder formulation, ...
Starting in 2025, the Eylea franchise as a whole began to decline due to competitive pressure from long-acting Vabysmo, which competes with Eylea HD, and Pabvlu, a biosimilar version of the original ...
Topical BRAF inhibitor LUT014 gel significantly reduces acneiform rash from anti-EGFR therapies in patients with colorectal ...
So what is it exactly that makes certain rom-coms stand out and endure while others are so quickly forgotten? We look back at ...
Persistence has paid off for Abeona Therapeutics and its gene therapy for recessive dystrophic epidermolysis bullosa (RDEB).